Eloxx Pharmaceuticals (ELOX)
Develops ribosome-modulating medicines for nonsense-mutation kidney diseases.
$16.11
Pre-market+0.08 (+0.50%)
At close$16.03(+6.80%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions22 holders · as of Jun 30, 2026 | 61.93% | 2.50M shares | |
| Insiders2 holders · as of Aug 14, 2026 | 13.76% | 555.5K shares | |
| Strategic holders2 holders · as of Jul 27, 2026 | 31.09% | 1.25M shares | |
| Adds to | 106.78% |
4.04M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (4.04M in the company's Sep 3, 2026 report, 3.44M elsewhere); stakes use the report.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
These groups come from separate filings that can overlap, so they add to 106.78%; nothing is left for Other.
Institutions13F, as of Jun 30, 2026
22 holders · 2.50M shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Ecor1 Capital, LLC | 400.0K | 9.91% | Aug 14, 2026 | |
| Siren, L.L.C. | 400.0K | 9.91% | Aug 13, 2026 | |
| Abrdn PLC | 400.0K | 9.91% | Jul 31, 2026 | |
| Samsara Biocapital, LLC | 400.0K | 9.91% | Aug 14, 2026 | |
| Nantahala Capital Management, LLC | 400.0K | 9.91% | Aug 19, 2026 | |
| Stonepine Capital Management, LLC | 397.2K | 9.84% | Aug 17, 2026 | |
| Vanguard Capital Management LLC | 78.7K | 1.95% | Aug 13, 2026 | |
| Vanguard Fiduciary Trust Co | 10.6K | 0.26% | Aug 13, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Domicilium Capital Partners LLC | 19.99% | 855.0K | 13G | Jun 17, 2026 ↗ |
| Domicilium Real Estate Fund III LP | 16.50% | 13G | May 4, 2026 ↗ | |
| Coastlands Capital LP | 9.99% | 410.5K | 13G | Jun 17, 2026 ↗ |
| Nantahala Capital Management, LLC | 9.91% | 400.0K | 13G | Aug 14, 2026 ↗ |
| Aberdeen Group plc | 9.91% | 400.0K | 13G | Jul 27, 2026 ↗ |
| EcoR1 Capital, LLC | 9.90% | 403.6K | 13G | Jun 16, 2026 ↗ |
| Stonepine Capital Management, LLC | 9.90% | 403.2K | 13G | Jun 16, 2026 ↗ |
| Invus Public Equities, L.P. | 8.80% | 353.7K | 13G | Jun 15, 2026 ↗ |
| Samsara BioCapital, L.P. | 5.00% | 201.8K | 13G | Aug 14, 2026 ↗ |
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.